NCT00452985View on ClinicalTrials.gov

Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Ovarian Neoplasms
Interventions
DRUG

Docetaxel

60-75 mg/m²

DRUG

Carboplatin

AUC 5

Trial Locations (1)

Unknown

Sanofi-Aventis, Dhaka

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY